A review of studies that have utilized different combinations of psoralenand ultraviolet B phototherapy and ultraviolet A phototherapy

Dermatology Online Journal

Volumn 9, Issue 5, 2003, Pages 68-75

  Scheinfeld, Noah ^a   Deleo, Vincent ^a  

^a St Lukes Roosevelt Hospital Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; METHOXSALEN; PSORALEN; PYRIMIDINE DERIVATIVE; INTERCALATING AGENT; PSORALEN DERIVATIVE; RADIOSENSITIZING AGENT;

APOPTOSIS; CELL PROLIFERATION; DNA SYNTHESIS; ERYTHEMA; MYCOSIS FUNGOIDES; PHOTOTHERAPY; PSORIASIS; PUVA; REVIEW; SKIN DISEASE; SKIN PIGMENTATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; VITILIGO; DNA DAMAGE; HUMAN; METHODOLOGY; SAFETY; ULTRAVIOLET RADIATION;

DNA DAMAGE; HUMANS; INTERCALATING AGENTS; PSORALENS; PUVA THERAPY; RADIATION-SENSITIZING AGENTS; SAFETY; SKIN DISEASES; ULTRAVIOLET RAYS;

EID: 3142545169     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Goeckerman WH. Treatment of psoriasis. Northwest Med 1925; 23: 229-231.
2. Goeckerman WH. Treatment of psoriasis: continued observations on the use of crude coal tar and ultraviolet light. Arch Dermatol 1931: 24: 446-450.
3. Marsico AR, Eaglstein WH. Role of long-wave ultraviolet light in Goeckerman treatment. Arch Dermatol. 1973;108:48-9.
4. Frost P, Horwitz SN, Caputo RV, Berger SM. Tar gel-phototherapy form psoriasis. Combined therapy with suberythemogenic doses of fluorescent sunlamp ultraviolet radiation. Arch Dermatol. 1979;115:840-6.
5. Markham T, Rogers S, Collins P. Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis. Arch Dermatol. 2003;139:325-8.
6. van Weelden H, De La Faille HB, Young E, van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol. 1988;119:11-9.
7. Coven TR, Burack LH, Gilleaudeau R, Keogh M, Ozawa M, Krueger JG. Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B. Arch Dermatol. 1997;133:1514-22.
8. Trosko JE, Isoun M. Photosensitizing effect of trisoralen on DNA synthesis in human cells grown in vitro. Int J Radiat Biol Relat Stud Phys Chem Med. 1971: 19: 87-92.
9. Yurkow EJ, Laskin JD. Mechanism of action of psoralens: isobologram analysis reveals that ultraviolet light potentiation of psoralen action is not additive but synergistic. Cancer Chemother Pharmacol. 1991: 27: 315-9.
10. Aboul-Enein HY, Kladna A, Kruk I, Lichszteld K, Michalska T. Effect of psoralens on Fenton-like reaction generating reactive oxygen species. Biopolymers. 2003: 72: 59-68.
11. Farr PM, Diffey BL, Higgins EM, Matthews JN. The action spectrum between 320 and 400 nm for clearance of psoriasis by psoralen photochemotherapy. Br J Dermatol. 1991: 124: 443-8.
12. Brucke J, Tanew A, Ortel B, Honigsmann H. Relative efficacy of 335 and 365 nm radiation in photochemotherapy of psoriasis. Br J Dermatol. 1991: 124: 372-4.
13. Ortel B, Gange RW. An action spectrum for the elicitation of erythema in skin persistently sensitized by photobound 8-methoxypsoralen. J Invest Dermatol 1990: 94: 781-5.
14. Cripps DJ, Lowe NJ, Lerner AB. Action spectra of topical psoralens: a re-evaluation. Br J Dermatol. 1982: 107: 77-82.
15. Coupez L, Agache PG, Petigny M. Effect of UV-B erythema of psoralen, trimethylpsoralen, and 8 methoxypsoralen. Acta Derm Venereol. 1980: 60:456-9
16. Agache PG, Coupez L. Protective effect of trimethylpsoralen against UV-B erythema. Arch Dermatol Res. 1980: 268: 85-9.
17. Garssen J, Vandebriel RJ, De Gruijl FR, Wolvers DA, Van Dijk M, Fluitman A, Van Loveren H. UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses. Immunology. 1999: 97: 506-14.
18. Habig J, Vocks E, Kautzky F, Dahm M, Borelli S. Effect of single UVA and UVB irradiation on the surface composition and viscoelastic properties of skin in vivo Hautarzt. 1996: 47: 515-20.
19. Clingen PH, Berneburg M, Petit-Frere C, Woollons A, Lowe JE, Arlett CF, Green MH. Contrasting effects of an ultraviolet B and an ultraviolet A tanning lamp on interleukin-6, tumour necrosis factor-alpha and intercellular adhesion molecule-1 expression. Br J Dermatol. 2001: 145: 54-62.
20. Duthie MS, Kimber I, Dearman RJ, Norval M. Differential effects of UVA1 and UVB radiation on Langerhans cell migration in mice. J Photochem Photobiol B. 2000: 57: 123-31.
21. Khurshid K, Haroon TS, Hussain I, Pal SS, Jahangir M, Zaman T. Psoralen-ultraviolet A therapy vs. psoralen-ultraviolet B therapy in the treatment of plaque-type psoriasis: our experience with Fitzpatrick skin type IV. Int J Dermatol. 2000: 39: 865-7.
22. de Berker DA, Sakuntabhai A, Diffey BL, Matthews JN, Farr PM. Comparison of psoralen-UVB and psoralen-UVA photochemotherapy in the treatment of psoriasis. J Am Acad Dermatol. 1997: 36: 577-81.
23. Morison WL. Combination of methoxsalen and ultraviolet B (UVB) versus UVB radiation alone in treatment of psoriasis: a bilateral comparison study. Photodermatol Photoimmunol Photomed. 1995: 11: 6-8.
24. Sakuntabhai A, Diffey BL, Farr PM. Response of psoriasis to psoralen-UVB photochemotherapy. Br J Dermatol. 1993: 128: 296-300.
25. Ortel B, Tanew A, Honigsmann H. Psoriasis therapy with 8-methoxypsoralen plus UVB (311 nm) radiation [Abstract]. Arch Dermatol Res 1991: 283: 44.
26. Ortel B, Perl S, Kinaciyan T, Calzavara-Pinton PG, Honigsmann H. Comparison of narrow-band (311 nm) UVB and broad-band UVA after oral or bath-water 8-methoxypsoralen in the treatment of psoriasis. J Am Acad Dermatol 1993: 29: 736-40.
27. Arnold WP, van Andel, de Hoop D, de Jong-Tieben L, Visser-van Andel M. A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. Br J Dermatol 2001: 145: 352-4.
28. Momtaz-T K, Parrish JA. Combination of psoralens and ultraviolet A and ultraviolet B in the treatment of psoriasis vulgaris: a bilateral comparison study. J Am Acad Dermatol 1984: 10: 481-6.
29. Diette KM, Momtaz-T K, Stern RS, Arndt KA, Parrish JA. Psoralens and UV-A and UV-B twice weekly for the treatment of psoriasis. Arch Dermatol. 1984: 120:1169-73.
30. Calzavara-Pinton P. Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination. J Am Acad Dermatol 1998: 38: 687-90.
31. Mofty ME, Zaher H, Esmat S, Youssef R, Shahin Z, Bassioni D, Enani GE. PUVA and PUVB in vitiligo-are they equally effective? Photodermatol Photoimmunol Photomed. 2001: 17: 159-63.
32. Mofty ME, Mostafa W, Esmat S, Hunter N, Hanaphy GE, Comparison of narrow band UVB 311 versus psoralen-UVB 311 in the treatment of vitiligo. 20th World Congress of Dermatology. Paris. P1783. July 4 2002.
33. Mofty ME, Darouti MAE, Sobeih S, Marzouk S, Leheta T. Comparison of psoralen-UVA and psoralen-UVB photochemotherapy in the treatment of mycosis fungoides 20th World Congress of Dermatology. Paris. P1784. July 4 2002.
34. Gathers RC, Scherschun L, Malick F, Fivenson DP, Lim HW. Narrowband UVB phototherapy for early-stage mycosis fungoides. J Am Acad Dermatol. 2002: 47: 191-7.
35. Lebwohl M. Should we switch from combination UVA/UVB phototherapy units to narrowband UVB? Photodermatol Photoimmunol Photomed. 2002: 18: 44-6, 48-9.
36. Shephard SE, Panizzon RG. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy. Dermatology. 1999: 199: 106-12.